R B Horenstein - Concepedia

Author

R B Horenstein

University of Maryland, Baltimore

Also Known As

R B Horenstein, R.B. Horenstein, RB Horenstein

Publications

380

Citations

H-Index

Concepts

All Affiliations

University of Maryland, Baltimore United States Department of Veterans Affairs Duke Medical Center Duke University Centre for Human Drug Research

About

R B Horenstein is an author at University of Maryland, Baltimore specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	196
2	Health Sciences	1	1	28
3	Public Health	1	1	16
4	Epidemiology	1	1	16
5	Immunology	1	1	28

R B Horenstein

Publications

380

Citations

H-Index

Page 1

	Year	Citations
The CYP2C19*17 variant is not independently associated with clopidogrel response Joshua P. Lewis, Sarah H. Stephens, R B Horenstein, Journal of Thrombosis and Haemostasis Molecular PharmacologyMedicineMolecular BiologyPharmacologyMolecular Medicine	2013	86
Paraoxonase 1 (PON1) Gene Variants Are Not Associated With Clopidogrel Response Joshua P. Lewis, Adam S. Fisch, Kathleen A. Ryan, Clinical Pharmacology & Therapeutics	2011	81
Purine Pathway Implicated in Mechanism of Resistance to Aspirin Therapy: Pharmacometabolomics-Informed Pharmacogenomics Laura M. Yerges‐Armstrong, Sandrine Ellero‐Simatos, Anastasia Georgiades, Clinical Pharmacology & Therapeutics	2013	68
Pharmacometabolomics Reveals That Serotonin Is Implicated in Aspirin Response Variability Sandrine Ellero‐Simatos, Anastasia Georgiades, L.M. Yerges-Armstrong, CPT Pharmacometrics & Systems Pharmacology ThrombosisMolecular PharmacologyHealthy SubjectsPsychiatryCardiovascular Disease	2014	66
Pharmacogenetics and Clopidogrel Response in Patients Undergoing Percutaneous Coronary Interventions A L Beitelshees, R B Horenstein, Mark R. Vesely, Clinical Pharmacology & Therapeutics	2011	35
Prospective Evaluation of Genetic Variation in Platelet Endothelial Aggregation Receptor 1 Reveals Aspirin‐Dependent Effects on Platelet Aggregation Pathways JD Backman, L.M. Yerges-Armstrong, R B Horenstein, Clinical and Translational Science ImmunologyPharmacotherapyPlatelet AggregationPlatelet Aggregation PathwaysInflammation	2017	28
Identifying clinically relevant sources of variability: The clopidogrel challenge S Samant, XL Jiang, LA Peletier, Clinical Pharmacology & Therapeutics Platelet ReactivityPharmacotherapyPhysiologically-based Pharmacokinetic ModelingThrombosisMetabolic Syndrome	2016	16

Page 1